X

Xiamen Amoytop Biotech Co Ltd
SSE:688278

Watchlist Manager
Xiamen Amoytop Biotech Co Ltd
SSE:688278
Watchlist
Price: 72.05 CNY 1.61% Market Closed
Market Cap: 29.3B CNY
Have any thoughts about
Xiamen Amoytop Biotech Co Ltd?
Write Note

Balance Sheet

Balance Sheet Decomposition
Xiamen Amoytop Biotech Co Ltd

Current Assets 1.3B
Cash & Short-Term Investments 670m
Receivables 459.7m
Other Current Assets 210.4m
Non-Current Assets 1B
Long-Term Investments 37.4m
PP&E 541.9m
Intangibles 352.7m
Other Non-Current Assets 84m
Current Liabilities 403.7m
Accounts Payable 40.6m
Accrued Liabilities 243.7m
Other Current Liabilities 119.3m
Non-Current Liabilities 76m
Long-Term Debt 3.8m
Other Non-Current Liabilities 72.3m

Balance Sheet
Xiamen Amoytop Biotech Co Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
135
84
145
206
197
285
300
413
Cash
0
0
0
0
0
285
300
413
Cash Equivalents
135
84
145
206
197
0
0
0
Short-Term Investments
0
0
0
0
268
196
271
257
Total Receivables
135
170
170
157
197
229
243
460
Accounts Receivables
122
150
111
124
163
186
217
438
Other Receivables
13
20
58
33
34
42
26
22
Inventory
31
41
55
71
100
116
130
187
Other Current Assets
2
1
4
12
11
8
11
23
Total Current Assets
302
295
374
445
773
834
956
1 340
PP&E Net
86
77
75
99
143
238
408
542
PP&E Gross
86
77
75
99
143
238
408
542
Accumulated Depreciation
98
110
122
135
142
147
169
195
Intangible Assets
243
253
231
219
250
310
342
353
Long-Term Investments
0
0
0
0
0
0
0
37
Other Long-Term Assets
12
12
28
27
28
42
64
84
Total Assets
643
N/A
637
-1%
708
+11%
790
+12%
1 193
+51%
1 424
+19%
1 770
+24%
2 356
+33%
Liabilities
Accounts Payable
4
3
10
20
19
39
97
41
Accrued Liabilities
28
27
31
39
49
76
113
244
Short-Term Debt
85
80
70
60
19
10
0
0
Current Portion of Long-Term Debt
3
0
0
0
0
6
4
4
Other Current Liabilities
13
8
19
32
28
46
53
115
Total Current Liabilities
132
119
130
151
115
177
268
404
Long-Term Debt
0
0
0
0
0
9
6
4
Deferred Income Tax
0
0
0
1
3
6
15
0
Other Liabilities
32
35
79
74
74
71
74
72
Total Liabilities
165
N/A
154
-6%
209
+35%
226
+9%
192
-15%
263
+37%
362
+38%
480
+32%
Equity
Common Stock
360
360
360
360
407
407
407
407
Retained Earnings
5
10
26
90
197
357
604
1 073
Additional Paid In Capital
113
113
113
113
397
397
397
397
Total Equity
478
N/A
483
+1%
499
+3%
564
+13%
1 000
+78%
1 161
+16%
1 408
+21%
1 876
+33%
Total Liabilities & Equity
643
N/A
637
-1%
708
+11%
790
+12%
1 193
+51%
1 424
+19%
1 770
+24%
2 356
+33%
Shares Outstanding
Common Shares Outstanding
360
360
360
360
407
407
407
407

See Also

Discover More